Clinical Trial

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a proof-of-concept, Open label, randomized, multicentric, superiority phase-2 study.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-04-06; most recent amendment 2026-04-09.
Status change: Not Yet Recruiting → Recruiting 2023-06-13
Trial Details
NCT Number NCT05821556
Lead Sponsor National Cancer Institute, Naples
Conditions Adenocarcinoma of the Pancreas
Enrollment 240 participants
Start Date 2023-06-12
Primary Completion 2026-08 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-14